Background: Selective chromogenic media allowing one-step meticillin-resistant Staphylococcus aureus (MRSA) isolation and identification are widely used. However, the changing epidemiology of MRSA means that the suitability of these chromogenic media requires investigation. Aim: To evaluate the following chromogenic media e Colorex MRSA, MRSA Select II, ChromID MRSA, and MRSA Brilliance 2 e for the detection of divergent strain types. Methods: We used a diverse collection of S. aureus, including strains harbouring the mecC gene, strains expressing varying levels of meticillin resistance, and isolates recovered from patient samples. Findings: MRSA Select II, Colorex MRSA, and ChromID each grew at a density of 1.5 Â 10 1 cfu/mL for each SCCmec type investigated. Brilliance 2 demonstrated growth at 1.5 Â 10 1 cfu/mL for mecC MRSA but at a higher density (1.5 Â 10 4 cfu/mL) for the three mecA MRSA strains. All four media demonstrated excellent sensitivity for MRSA detection (!99%), but reduced levels of specificity (85e73%) when challenged with a range of meticillin-susceptible S. aureus (MSSA) isolates. High levels of false positives (w50%) were also obtained with all chromogenic media when tested with mec-negative borderline oxacillin-resistant S. aureus (BORSA) isolates. Conclusion: Although false positives may be obtained with some strains of MSSA and BORSA, the high sensitivity of these media and their ability to recover almost all MRSA tested (including oxacillin-susceptible and mecC-positive strains) confirm the value of chromogenic agar in MRSA detection. ª
Introduction
Meticillin-resistant Staphylococcus aureus (MRSA) are major healthcare-associated pathogens frequently associated with serious and sometimes life-threatening conditions. Meticillin resistance is mediated by an altered penicillin binding protein PBP2a encoded by mec and located on the staphylococcal cassette chromosome mec (SCCmec) element. To date, 11 different SCCmec elements have been described in staphylococci corresponding to the emergence of a wide range of MRSA strains with different genetic backgrounds. 1 In the last two decades the epidemiology of MRSA has changed significantly with an increasing prevalence of MRSA infections outside the healthcare environment in the community, and more recently among livestock. 2, 3 In Ireland, MRSA is endemic in hospitals, and, as in many countries throughout Europe, the sequence type-SCCmec ST22-MRSA-IV clone predominates. 4 In addition, a diversity of other strains including community-associated pvl toxin-positive and -negative MRSA along with a small number of livestock-associated strains have also been reported in Ireland. 2, 3 Just as the epidemiology of MRSA has changed, so too has the level of meticillin resistance among MRSA. Traditionally MRSA are defined as having an oxacillin minimum inhibitory concentration (MIC) !4.0 mg/L or as harbouring the mecA gene encoding PBP2a. 1 However, few MRSA isolates express homogeneous oxacillin resistance. Oxacillin-susceptible mecA-positive S. aureus isolates have been reported worldwide. 5 Similarly, lowlevel oxacillin-resistant mecA-negative strains known as borderline oxacillin-resistant S. aureus (BORSA) isolates have further complicated the definition of MRSA. 6 Superimposed on this heterogeneous expression of meticillin resistance, recent reports have also identified a variety of MRSA strains of probable animal origin that encode a highly divergent meticillin-resistance gene termed mecC. Where once the detection of mecA was considered the gold standard in laboratory confirmation of MRSA, the emergence of mecCencoding strains in infection in both humans and animals adds to the challenge of defining and detecting an MRSA-positive patient.
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Regardless of the changing epidemiology of MRSA, rapid detection remains essential for the implementation of infection control procedures and effective patient management. The use of selective chromogenic culture media, which allow for one-step MRSA isolation and identification, has now become widespread practice. 10, 11 With the frequent application of chromogenic media in diagnostic practice, the suitability of these media to ensure the correct detection of divergent MRSA strain types has come under review. However, whereas many studies have evaluated the use of chromogenic media for the direct recovery of MRSA from patient specimens, few have undertaken a comparative evaluation of all currently available commercial media using a comprehensive collection of diverse S. aureus strains, including those with the novel mecC gene and those expressing varying levels of meticillin resistance. The purpose of this study was to evaluate the performance of widely used chromogenic MRSA media using a diverse collection of S. aureus isolates recovered in Ireland and Europe. The limits of detection (LOD) of four commercial chromogenic media were determined using MRSA strains representative of four SCCmec types, i.e. II, IV, V, and XI. 2, 3, 7 The performance of the media was also evaluated against a collection of genotypically diverse MRSA strains from hospitals, communities, and livestock and representative of SCCmec types IeVIII, X, and XI as well as meticillin-susceptible S. aureus (MSSA) and BORSA strains isolated from healthcare and community sources. An evaluation of the media was also undertaken using patient samples collected as part of the routine infection prevention and control procedures in a large teaching hospital.
Methods

Limits of detection
Four MRSA isolates, representative of SCCmec types II, IV, and V (carrying mecA) and SCCmec XI (carrying mecC) (Table I) were selected to investigate the LOD of the following four commercial MRSA chromogenic agars: MRSA Select II (BioRad, Hercules, CA, USA), MRSA Brilliance 2 (Oxoid, Basingstoke, UK), Colorex MRSA (E & O Laboratories, Bonnybridge, UK), and ChromID MRSA (bioMérieux, Marcy l'Etoile, France). In each case, isolates were subcultured overnight on Columbia blood agar (Oxoid) at 37 C and then suspended in saline to a density equivalent to 0.5 McFarland standard. A ten-fold dilution series was prepared from 1.5 Â 10 8 À10 0 colony-forming units (cfu)/ mL and a standard volume (100 mL) of each dilution was inoculated on to each of the MRSA chromogenic agars using a spiral plater (Don Whitley Scientific, Shipley, UK). This application was performed in triplicate for each isolate and plates were incubated as per the manufacturer's instructions. In each case, MRSA recovery was observed in accordance with the manufacturer's description of MRSA colony type, i.e. pink colonies on MRSA Select II, Colorex, and ChromID, or blue colonies on MRSA Brilliance 2. The LOD was recorded as the lowest bacterial density to give detectable growth on the chromogenic agar.
Evaluation of chromogenic media using a diverse collection of S. aureus isolates
The ability of the media to detect MRSA among a diverse collection of S. aureus isolates was also investigated. This included: (i) MRSA isolates representing 10/11 SCCmec types MRSA, meticillin-resistant Staphylococcus aureus. a The limit of detection was recorded as the lowest bacterial density to give detectable growth on chromogenic media.
(IeVIII, X and XI); (ii) mecA-positive (n ¼ 148) and mecC-positive (n ¼ Table I ). In each case, isolates were suspended to a density equivalent to 0.5 McFarland standard. A 20 mL volume was inoculated on to each of the four commercial MRSA chromogenic agars, and plates were incubated and read as above. Quality control testing was performed on each medium using S. aureus control strains ATCC43300 (MRSA) and ATCC25923 (MSSA).
Evaluation of chromogenic media using patient samples
The ability of the chromogenic media to detect MRSA directly from patient samples was investigated using 228 swabs recovered from the nose, throat, and groin of 76 inpatients at a 936-bed tertiary referral hospital in Dublin, Ireland. Specimens were collected as part of routine screening practices within the hospital. The 228 samples were initially inoculated on to MRSA Select (the earlier formulation of MRSA Select II) in accordance with the routine diagnostic procedures. The specimens were then inoculated on to the test chromogenic agars, changing the order in which the media were inoculated for each sample. All suspect colonies recovered from the screening swabs that were consistent with the manufacturer's description of MRSA were tested for oxacillin susceptibility by disc diffusion and investigated for the presence of mec and nuc genes using an in-house real-time polymerase chain reaction assay. 15 
Statistical analysis
The ability of each agar to correctly identify MRSA (sensitivity) and to exclude MSSA (specificity) was determined based on the number of correct results realized among the MRSA and MSSA isolates.
Results
Limits of detection assay
The results of the LOD evaluation for the four MRSA strains on the four different chromogenic agars tested are shown in Table I . The MRSA Select II, Colorex MRSA, and ChromID each yielded growth at a density of 1.5 Â 10 1 cfu/mL for each SCCmec/mec gene type investigated. Brilliance 2 also demonstrated growth at 1.5 Â 10 1 cfu/mL for the mecC MRSA but at a higher density (1.5 Â 10 4 cfu/mL) for each of the three mecA MRSA strains tested. For each strain and each agar tested, the results from the three experiments were in agreement with each other.
Performance of the chromogenic media using a diverse collection of S. aureus isolates
The MRSA strains representative of the different SCCmec types demonstrated good recovery with typical MRSA morphology on all four media tested. The performance data for the MRSA and MSSA isolates on the four chromogenic media are shown in Table II . For the 161 MRSA isolates, Colorex MRSA and ChromID MRSA were found to be 100% sensitive whereas MRSA Select II and MRSA Brilliance 2 demonstrated slightly lower sensitivity rates of 99% and 98%, respectively. MRSA Select II and MRSA Brilliance 2 failed to detect one mecA-positive MRSA isolate, exhibiting an oxacillin MIC of only 0.125 mg/L (spa type t2235), and Brilliance 2 failed to detect an additional two MRSA isolates, exhibiting susceptible MICs of 1.0 and 2.0 mg/L (spa types t002 and t3500, respectively). When compared with the predominant ST22-MRSA-IV mecA strain, mecC isolates included in this study yielded colonies equivalent in number and morphology on three of the four chromogenic agars tested and yielded a greater number of colonies on the Brilliance 2 agar.
When tested with the 34 MSSA isolates, the specificity of the four chromogenic agars ranged between 73% and 85% (Table II) . The MRSA Select II exhibited the highest number of falsepositive results (9 out of 25) whereas other chromogenic agars yielded five or six false positives (Table III) . All isolates that generated false positives on the chromogenic agars exhibited oxacillin susceptibilities representative of the range of oxacillin MIC values in the MSSA collection tested and belonged to a range of genotypes (Table III) .
As expected, due to their higher oxacillin MICs (4e8 mg/L), the BORSA isolates also proved challenging for the chromogenic agars. Once again MRSA Select II exhibited the highest number of false-positive results, with 13 out of 20 BORSA isolates yielding suspect MRSA colonies. The other three chromogenic agars also produced a high number of false positives with Brilliance 2 and Colorex demonstrating growth for 11 of the BORSA whereas eight were recovered on the ChromID (Table III) .
Performance of the chromogenic media using patient samples
Of the 228 swabs investigated from 76 patients, six swabs from four patients were positive for MRSA (one patient nose and groin swab positive; two patients groin swab only positive; one patient throat swab only positive). These results were in agreement with the clinical microbiology laboratory results and were detected with all four chromogenic agars, with suspect colonies growing in sufficient numbers and with typical colony morphology that allowed ready detection despite the high number of plates inoculated. All isolates were confirmed as oxacillin resistant and carried the mecA gene.
Discussion
Although the decreasing level of invasive healthcareassociated MRSA infections in Europe and the USA is encouraging, the changing epidemiology of this pathogen and the emergence of virulent strains in the community require rapid and sensitive laboratory detection. For the detection of MRSA all media performed well in the evaluation. With the exception of MRSA Brilliance 2, which demonstrated growth at a higher density (15,000 cfu/mL) for the three mecA MRSA, the other three chromogenic agars e MRSA Select II, Colorex MRSA, and ChromID e recovered all strains (mecA and mecC MRSA) when challenged with lower densities at 15 cfu/mL. Previously reported studies of mecC isolates suggested that difficulties may arise in the laboratory detection of mecC-positive MRSA isolates due to the low oxacillin MIC exhibited by some of these strains. 9, 19, 20 However, the mecC isolates included in this study grew well on each of the chromogenic media investigated, and showed even improved recovery on MRSA Brilliance 2 compared to mecA-and healthcare-associated MRSA strains, e.g. ST22-MRSA-IV. The underlying reasons for this disparity between mecA and mecC MRSA strains on Brilliance 2 agar are unclear but may reflect differential interactions between the mec gene products and constituents of the medium. 21 This requires further study. The chromogenic agars demonstrated excellent sensitivity ranging from 98% to 100%, with Colorex media and ChromID detecting the full collection of MRSA isolates investigated. The high sensitivities recorded here are in agreement with other MRSA chromogenic agar evaluation studies.
11e13 However, a challenge arose for the MRSA Select II and MRSA Brilliance 2 media: each failed to detect a small number of MRSA isolates (one and three isolates, respectively) exhibiting susceptible oxacillin MICs. A small increase in the prevalence of oxacillinsusceptible mecA-positive isolates has been previously reported elsewhere and similar isolates have been recovered in the National MRSA Reference Laboratory in Ireland. 5 As these strains can cause problems in the routine diagnostic laboratory, their successful recovery using the chromogenic media is essential.
When challenged with MSSA isolates the chromogenic agars demonstrated reduced levels of specificity, ranging from 73% to MIC, minimum inhibitory concentration; MSSA, meticillin-susceptible S. aureus; BORSA, borderline-oxacillin resistant S. aureus; MRSA, meticillinresistant Staphylococcus aureus; pos; positive, neg; negative; ND, not determined. a Where available genotypes are indicated by the multi-locus sequence type (prefix 'ST') and/or the spa type (prefix 't'). The STs were inferred from the spa type using the Ridom spa server (http://www.spaserver.ridom.de/) and/or based on previous experience at the Irish National MRSA Reference Laboratory (NMRSARL).
85%. This specificity rate is low in comparison to other studies where specificity rates of 95e99% have been reported for chromogenic agars. 11e13 However, these other studies confined investigations to clinical specimens only, whereas the current study included a diverse collection of MSSA strains. The recovery of these MSSA strains as presumptive MRSA isolates has implications for the diagnostic laboratory in terms of increasing the turnaround time and resource management. 11 The reduced specificity of the chromogenic agars was once again demonstrated by the high recovery of BORSA with almost 50% of isolates being recovered on all four of the media. This high rate of false positivity can be expected with the BORSA isolates due to their high oxacillin MICs. Although a previous epidemiological investigation of BORSA isolates indicated that they are not implicated in patient-to-patient spread, their growth on this medium further complicates the detection, prevention, and control of genuine MRSA in the healthcare environment. 22 Despite the investigation of a relatively large number of patient samples (nose, throat, and groin from 76 patients, i.e. 228 samples) the rate of detection of MRSA was low (5.6%). However, this was similar to previous studies of patient samples from hospitalized patients in Ireland which showed MRSA prevalence rates of 8.5% and 7.6%. 23, 24 Additionally, the results correlated with the clinical microbiology laboratory results for these samples, indicating that no false positives or false negatives were detected using any of the four chromogenic agars.
The early identification of MRSA and implementation of infection prevention and control procedures has been shown to reduce healthcare-associated infections. The high sensitivity of the chromogenic agars evaluated in this study confirms the usefulness of this medium in the one-step detection and presumptive identification of MRSA. Whereas the recovery of a high number of MSSA and BORSA isolates is a concern, the ability of the medium to recover almost all MRSA, including oxacillin-susceptible and mecC-positive strains, ensures appropriate management and treatment for MRSA-positive patients.
